1994
DOI: 10.1378/chest.106.6.1766
|View full text |Cite
|
Sign up to set email alerts
|

Elevated Surfactant Protein A in Bronchoalveolar Lavage Fluids From Sarcoidosis and Hypersensitivity Pneumonitis Patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
52
0

Year Published

1996
1996
2012
2012

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 68 publications
(56 citation statements)
references
References 18 publications
4
52
0
Order By: Relevance
“…This is in concordance with studies in adults where a wide range of concentrations has been observed in healthy subjects, although significant difference have been observed between healthy individuals and patients with pulmonary disease [32][33][34]. We have observed a weak correlation between SP-A and the total phospholipid content for the group as a whole; however, the r-value of 0.46 would imply that only 20% of the variability is explained by the variation in phospholipid concentrations.…”
Section: +2 Sdsupporting
confidence: 91%
“…This is in concordance with studies in adults where a wide range of concentrations has been observed in healthy subjects, although significant difference have been observed between healthy individuals and patients with pulmonary disease [32][33][34]. We have observed a weak correlation between SP-A and the total phospholipid content for the group as a whole; however, the r-value of 0.46 would imply that only 20% of the variability is explained by the variation in phospholipid concentrations.…”
Section: +2 Sdsupporting
confidence: 91%
“…Inconsistent results also have been reported with regard to the effects of smoking on levels of SP-A in lavage fluids, which were decreased [15], slightly increased [16], or unchanged [17]. However, no changes were observed in rats exposed to cigarette smoke [18].…”
Section: Discussionmentioning
confidence: 74%
“…Reduced or unchanged SP-A and SP-D levels in BALF from clinically stable patients with cystic fibrosis have also been reported, but increased levels have been found when the disease progressed as a result of infection (30,31). SP-A or SP-D levels in BALF of pulmonary sarcoidosis patients have been reported to be increased (7,32), unchanged (7), or reduced (27,29). Increased SP-A or SP-D levels in BALF of pneumocystis carinii pneumonia (33) and pulmonary alveolar proteinosis (PAP) (29) have been reported.…”
Section: Discussionmentioning
confidence: 99%